Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 10Unknown 6Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Endocrine 1

Conditions

Smoldering Multiple Myeloma 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Growth Hormone-Secreting Pituitary Adenoma 1

Interventions

Blood Specimen Collection 106Standard of Care 82Exercise 68Radiotherapy 54Radiosurgery 47Magnetic Resonance Spectroscopy 46Specimen Handling 45Practice Guidelines as Topic 44Surveys and Questionnaires 43Interviews as Topic 43Educational Status 42Methods 41Drug Therapy 34Early Intervention, Educational 30Surgical Procedures, Operative 29Palliative Care 25Biopsy 24Control Groups 21venetoclax 17Therapeutics 17Patient Navigation 17Cisplatin 17Proton Therapy 15Magnetic Resonance Imaging 15Behavior Therapy 15Neoadjuvant Therapy 14Cognitive Behavioral Therapy 13Acupuncture Therapy 13Resistance Training 12Nutritional Status 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Diet, Mediterranean × Clear all
NCT07446777 2026-05-01

FAST-M

University of Miami

Phase NA Recruiting
120 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT06949891 2025-04-29

KETOACRO

Erasmus Medical Center

Phase NA Recruiting
60 enrolled
Endocrine

Growth Hormone-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡